The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for LD Cantin


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.EBI
Mcgill University
Discovery of P2X3 selective antagonists for the treatment of chronic pain.EBI
Astrazeneca
Synthesis of a substance P antagonist with a somatostatin scaffold: factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry.EBI
University of Pennsylvania
Indanylacetic acids as PPAR-delta activator insulin sensitizers.EBI
Bayer Research Center
PDE-10A inhibitors as insulin secretagogues.EBI
Bayer Pharmaceuticals
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists.EBI
Bayer Pharmaceuticals
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.EBI
Astrazeneca
Cyclic sulfonamides as sodium channel blockersBDB
Purdue Pharma
N-substituted-5-substituted phthalamic acids as sortilin inhibitorsBDB
H. Lundbeck